Bofanglutide injection: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2a Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bofanglutide ...

CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association ® (ADA) celebrates its 85 th anniversary, it continues to fuel transformative progress in the fight to end diabetes ...

Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn).

This research highlights the association between AMY1 gene copy number and salivary enzyme activity, with implications for ...

GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...

Cardiovascular Efficacy of Evolocumab in Persons with Type 1 Diabetes Mellitus: Insights from FOURIER Trial Abstract #1991, Abstract Session: Sunday, June 22 from 12:30 p.m. - 1:30 p.m. CDT ...

BURLINGTON, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes ...

BEIJING and BRIDGEWATER, N.J., June 21, 2025 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, stock code: 603087.SH) announced that the company presented multiple Phase 2 clinical study results ...

It may take some time to get a handle on your diabetes medications, but doing so can both save time and reduce stress, says Dr. Bhatia. “For example, people may feel a stigma about using pill ...

Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA) Provided by GlobeNewswire Jun 23, 2025, 4:00:00 AM ...

SUZHOU, China, June 23, 2025 /CNW/ -- BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...

Proteomics International Laboratories has officially launched the US rollout of its PromarkerD kidney diagnostic test at a conference in Chicago attended by the world’s largest gathering of ...